Recombinant angiotensin II therapy in a child with cardiac dysfunction and Pandoraea and Candida sepsis

In brief

This case report describes successful use of recombinant angiotensin II for refractory hypotension in a pediatric patient with right ventricular dysfunction and polymicrobial sepsis caused by Pandoraea and Candida species. The therapy targeted disrupted renin-angiotensin-aldosterone system physiology, offering a novel approach for vasopressor-resistant shock in complex critical care scenarios.

Written by the GCMD Library team from the article.